Immunotherapy achieves remarkable survival rates in a handful of tumors
A new study reveals that almost half of patients with metastatic melanoma treated with these drugs were cancer-free 10 years later
_
_
A new study reveals that almost half of patients with metastatic melanoma treated with these drugs were cancer-free 10 years later